tradingkey.logo

Inspire Medical Systems Inc

INSP
66.330USD
+0.630+0.96%
收盘 02/09, 16:00美东报价延迟15分钟
1.34B总市值
44.24市盈率 TTM

Inspire Medical Systems Inc

66.330
+0.630+0.96%

关于 Inspire Medical Systems Inc 公司

Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. It has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.

Inspire Medical Systems Inc简介

公司代码INSP
公司名称Inspire Medical Systems Inc
上市日期May 03, 2018
CEOHerbert (Timothy P)
员工数量1246
证券类型Ordinary Share
年结日May 03
公司地址5500 Wayzata Blvd Ste 1600
城市GOLDEN VALLEY
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家United States of America
邮编55416-1237
电话17639575037
网址https://www.inspiresleep.com/
公司代码INSP
上市日期May 03, 2018
CEOHerbert (Timothy P)

Inspire Medical Systems Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Timothy P. (Tim) Herbert
Mr. Timothy P. (Tim) Herbert
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
77.13K
-294921.00%
Mr. Casey M. Tansey
Mr. Casey M. Tansey
Independent Director
Independent Director
23.42K
+181.00%
Mr. Bryan K. Phillips, J.D.
Mr. Bryan K. Phillips, J.D.
Senior Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
Senior Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
6.36K
-4865.00%
Ms. Shelley G. Broader
Ms. Shelley G. Broader
Independent Director
Independent Director
4.57K
+200.00%
Mr. Jason P. Kelly
Mr. Jason P. Kelly
Chief Manufacturing and Quality Officer
Chief Manufacturing and Quality Officer
4.54K
+4541.00%
Dr. Myriam J. Curet, M.D.
Dr. Myriam J. Curet, M.D.
Independent Director
Independent Director
3.37K
-4.00%
Mr. Randall A. (Randy) Ban
Mr. Randall A. (Randy) Ban
Executive Vice President - Patient Access and Therapy Development
Executive Vice President - Patient Access and Therapy Development
--
--
Mr. Richard J. (Rick) Buchholz
Mr. Richard J. (Rick) Buchholz
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Dana G. Mead, Jr.
Mr. Dana G. Mead, Jr.
Independent Director
Independent Director
--
--
Mr. Shawn T. Mccormick
Mr. Shawn T. Mccormick
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Timothy P. (Tim) Herbert
Mr. Timothy P. (Tim) Herbert
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
77.13K
-294921.00%
Mr. Casey M. Tansey
Mr. Casey M. Tansey
Independent Director
Independent Director
23.42K
+181.00%
Mr. Bryan K. Phillips, J.D.
Mr. Bryan K. Phillips, J.D.
Senior Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
Senior Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
6.36K
-4865.00%
Ms. Shelley G. Broader
Ms. Shelley G. Broader
Independent Director
Independent Director
4.57K
+200.00%
Mr. Jason P. Kelly
Mr. Jason P. Kelly
Chief Manufacturing and Quality Officer
Chief Manufacturing and Quality Officer
4.54K
+4541.00%
Dr. Myriam J. Curet, M.D.
Dr. Myriam J. Curet, M.D.
Independent Director
Independent Director
3.37K
-4.00%

收入明细

单位: USD更新时间: 1月6日 周二
单位: USD更新时间: 1月6日 周二
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
由于公司未披露,未能获取相关数据
地区USD
名称
营收
占比
United States
214.39M
95.50%
All other countries
10.11M
4.50%
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 2月2日 周一
更新时间: 2月2日 周一
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
10.97%
The Vanguard Group, Inc.
10.14%
Wellington Management Company, LLP
6.03%
Citadel Advisors LLC
5.90%
Deerfield Management Company, L.P.
5.08%
其他
61.88%
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
10.97%
The Vanguard Group, Inc.
10.14%
Wellington Management Company, LLP
6.03%
Citadel Advisors LLC
5.90%
Deerfield Management Company, L.P.
5.08%
其他
61.88%
股东类型
持股股东
占比
Investment Advisor
45.18%
Investment Advisor/Hedge Fund
32.82%
Hedge Fund
27.41%
Research Firm
7.27%
Pension Fund
2.17%
Sovereign Wealth Fund
0.96%
Individual Investor
0.87%
Bank and Trust
0.59%
Venture Capital
0.42%

机构持股

更新时间: 1月1日 周四
更新时间: 1月1日 周四
报告期
机构数
持股数
持股占比
持股变动
2025Q4
829
33.78M
116.26%
-6.67M
2025Q3
828
32.29M
111.12%
-7.29M
2025Q2
883
35.48M
119.97%
-4.91M
2025Q1
912
35.71M
121.08%
-5.66M
2024Q4
874
35.22M
118.69%
-4.72M
2024Q3
852
35.48M
118.45%
-2.86M
2024Q2
825
33.60M
112.73%
-2.85M
2024Q1
801
33.20M
111.87%
-2.01M
2023Q4
786
32.35M
109.45%
+751.92K
2023Q3
753
29.93M
101.80%
-635.63K
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
3.19M
10.97%
-303.16K
-8.69%
Sep 30, 2025
The Vanguard Group, Inc.
2.99M
10.3%
-203.50K
-6.37%
Sep 30, 2025
Citadel Advisors LLC
1.71M
5.9%
-35.37K
-2.02%
Oct 06, 2025
Deerfield Management Company, L.P.
1.48M
5.08%
+428.61K
+40.91%
Nov 06, 2025
William Blair Investment Management, LLC
1.30M
4.47%
+528.40K
+68.70%
Sep 30, 2025
State Street Investment Management (US)
979.31K
3.37%
-51.59K
-5.00%
Sep 30, 2025
Braidwell LP
883.75K
3.04%
+361.34K
+69.17%
Sep 30, 2025
Soleus Capital Management, L.P.
728.19K
2.51%
+619.19K
+568.06%
Sep 30, 2025
Janus Henderson Investors
667.08K
2.3%
+26.16K
+4.08%
Sep 30, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Global X HealthTech ETF
2.68%
State Street SPDR S&P Health Care Equipment ETF
1.63%
Invesco S&P SmallCap Health Care ETF
1.19%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.71%
Invesco S&P SmallCap 600 Pure Growth ETF
0.53%
iShares S&P Small-Cap 600 Growth ETF
0.43%
VictoryShares Small Cap Free Cash Flow ETF
0.36%
Invesco S&P SmallCap 600 QVM Multi-factor ETF
0.34%
State Street SPDR S&P 600 Small Cap Growth ETF
0.27%
WisdomTree US SmallCap Quality Growth Fund
0.26%
查看更多
Global X HealthTech ETF
占比2.68%
State Street SPDR S&P Health Care Equipment ETF
占比1.63%
Invesco S&P SmallCap Health Care ETF
占比1.19%
First Trust Nasdaq Lux Digi Health Solutions ETF
占比0.71%
Invesco S&P SmallCap 600 Pure Growth ETF
占比0.53%
iShares S&P Small-Cap 600 Growth ETF
占比0.43%
VictoryShares Small Cap Free Cash Flow ETF
占比0.36%
Invesco S&P SmallCap 600 QVM Multi-factor ETF
占比0.34%
State Street SPDR S&P 600 Small Cap Growth ETF
占比0.27%
WisdomTree US SmallCap Quality Growth Fund
占比0.26%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
KeyAI